Products

Leapility

AI-nativeMCP

Turn Your Expertise Into Agentic Assets That Earn 24/7.

leapility.com DiscordAI Models & Agents / Agent Builders & Platforms

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Usage-based
No monthly subscription pricing
Creators
Zack
@leapility· 34 followers
Launched
10mo ago
2026-01-30 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@leapility
  • Launched on Product HuntLaunch

    Turn your repetitive workflows into AI-powered playbooks

    Jan 30 · 10mo agoLaunch page

MCP Server & Agent Ecosystem

GitHub · MCP / Skill

Agent, MCP & Developer Integration

MCP Server
Exposed tool capabilities:
Agent MarketplaceBlack-box delivery
Browse all MCP Server products →

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2024-12-15

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Usage-based pricing; no fixed plans listed on website.

Trial: None · Observed 2026-11-07 · Source page

Pages & changes

Tracked since 2026-01-30

Key pages

Weekly snapshots
www.leapility.com/ Snapshot 2026-11-07

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Leapility get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Leapility and what platforms does it support?
Leapility is catalogued under Agent Builders & Platforms: Turn Your Expertise Into Agentic Assets That Earn 24/7. Supported platforms: Web.

Related products in this category

AI Models & Agents / Agent Builders & Platforms

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.